Based on the course resources, Virtual Crash Lab evidence collection, your personal research, etc., on the topic of the field investigation you are completing this week, post and discuss with peers one example artifact you will or are considering incorporating into your final portfolio, which demonstrates evidence of your critical thought, acumen, and application on the topics.
The intent of this collegial dialogue goes beyond faculty feedback and vectors, to gaining and sharing other perspectives on higher order learning objectives specific to the four subject-specific investigative techniques and applications. Regardless of whether your exploration this week is specific to human factors, survivability, systems or structures, the overarching objectives is to demonstrate achievement of two primary aspects of the specific topic you cover each week: subject-specific investigative tools and techniques and the influence of accident investigation findings and recommendations specific to the topic you explored this week, on aviation safety. As you post your exemplar, note that your peers will be posting on and discussing any of the four topic areas this week, depending on the order of topics they chose in Part II, but that they too are focusing on investigative tools and techniques and the influence to aviation safety, for their specific topic. This gives each of you the opportunity to be exposed to varying perspectives and artifact examples, on all four subject areas, every week.
Sample Solution
Growth hormone: Prader Willi syndrome ⢠Octreotide: Hypothalamic obesity ⢠Leptin: Leptin deficiency The FDA approved a number of weight-loss medications for adults and these medications are appropriate for those â¥16 years of age with BMI â¥30kg/m2 or who have BMI â¥27 kg/m2 and at least one weight related comorbidity (e.g., hypertension or T2DM). Medication should be discontinued and the child should be re-evaluated if he/she does not have a 0.4% BMI/BMI z-score reduction after taking full dose of anti-obesity medication for 12 weeks. BARIATRIC SURGERY Pre-requisites (Endocrine Society recommendations): 1) Adolescent Tanner 4-5, and final/near final adult height. 2) BMI 40kg/m2 or BMI >35kg/m2 and significant extreme comorbidities. 3) Extreme obesity and co-morbidities persist despite lifestyle modification, with or without trial of pharmacotherapy. 4) Psychological evaluation confirms stability & competence of the family 5) Patient demonstrates ability to adhere to the principles of healthy dietary and activity habits. 6) Access to experienced surgeon in medical center. Contraindications of bariatric surgery: preadolescents, pregnant/ breastfeeding, unresolved eating disorder, untreated psychiatric disorder, or Prader-Willi syndrome. PREVENTION Lifestyle behaviors to prevent obesity, rather than intervention to lose weight should be aimed in all children. Efforts must begin early in life, because childhood obesity usually persists into adulthood. Exclusive breastfeeding should be encouraged till 6months of age and maintenance of breastfeeding after introduction of solid food till 12 months of age. Children should limit consumption of sugar-sweetened beverages and fast foods, limit screen time, and consume well balanced diet. Consumption of whole fruits should be encouraged rather than fruit juices. Children and adolescents should engage in at least 20 minutes, ideally 60 minutes, of vigorous physical activity at least 5 days per week to improve metabolic h>
Growth hormone: Prader Willi syndrome ⢠Octreotide: Hypothalamic obesity ⢠Leptin: Leptin deficiency The FDA approved a number of weight-loss medications for adults and these medications are appropriate for those â¥16 years of age with BMI â¥30kg/m2 or who have BMI â¥27 kg/m2 and at least one weight related comorbidity (e.g., hypertension or T2DM). Medication should be discontinued and the child should be re-evaluated if he/she does not have a 0.4% BMI/BMI z-score reduction after taking full dose of anti-obesity medication for 12 weeks. BARIATRIC SURGERY Pre-requisites (Endocrine Society recommendations): 1) Adolescent Tanner 4-5, and final/near final adult height. 2) BMI 40kg/m2 or BMI >35kg/m2 and significant extreme comorbidities. 3) Extreme obesity and co-morbidities persist despite lifestyle modification, with or without trial of pharmacotherapy. 4) Psychological evaluation confirms stability & competence of the family 5) Patient demonstrates ability to adhere to the principles of healthy dietary and activity habits. 6) Access to experienced surgeon in medical center. Contraindications of bariatric surgery: preadolescents, pregnant/ breastfeeding, unresolved eating disorder, untreated psychiatric disorder, or Prader-Willi syndrome. PREVENTION Lifestyle behaviors to prevent obesity, rather than intervention to lose weight should be aimed in all children. Efforts must begin early in life, because childhood obesity usually persists into adulthood. Exclusive breastfeeding should be encouraged till 6months of age and maintenance of breastfeeding after introduction of solid food till 12 months of age. Children should limit consumption of sugar-sweetened beverages and fast foods, limit screen time, and consume well balanced diet. Consumption of whole fruits should be encouraged rather than fruit juices. Children and adolescents should engage in at least 20 minutes, ideally 60 minutes, of vigorous physical activity at least 5 days per week to improve metabolic h>
